Valiant Organics Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.6 pts less than Nifty Microcap 250 and 5.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Organics Limited submitted its unaudited standalone and consolidated financial results for Q3 FY26 and 9M FY26 (period ended December 31, 2025), approved by the Board on February 13, 2026. Standalone revenue from operations fell about 14.9% year-on-year to Rs. 15,906.97 lakhs in Q3, but for the 9-month period revenue edged up slightly to Rs. 52,068.29 lakhs from Rs. 51,494.99 lakhs. Standalone net profit jumped to Rs. 606.36 lakhs in Q3 (up roughly 30% from Rs. 464.60 lakhs) and swung to a profit of Rs. 1,923.82 lakhs for 9M FY26 from a loss of Rs. 695.44 lakhs a year earlier. The company booked an exceptional gain of Rs. 572.08 lakhs from a fire insurance claim related to its Sarigam Division incident of FY22-23. Consolidated net profit for 9M was Rs. 1,750.92 lakhs, pulled down by a Rs. 241.75 lakhs share of losses from associate companies. Statutory auditor Gokhale & Sathe issued an unqualified limited review report.
The sharp swing back to profitability, supported by lower input and finance costs plus a one-time insurance gain, is a positive signal for shareholders, though softer Q3 revenue and associate-level losses may limit near-term enthusiasm.